FAT1 upregulation is correlated with an immunosuppressive tumor microenvironment and predicts unfavorable outcome of immune checkpoint therapy in non-small cell lung cancer
2024 · Heliyon · 5 citations
https://doi.org/10.1016/j.heliyon.2024.e28356
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
230
Citations
5
h-index
5
i10-index
Mengying Liao is an academic researcher from Peking University Shenzhen Hospital. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Epigenetics and DNA Methylation & Cardiac tumors and thrombi. The author has an h-index of 5, co-authored 14 publications.
https://doi.org/10.1016/j.heliyon.2024.e28356
https://doi.org/10.1016/j.heliyon.2024.e35012
Click to start Chat